These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31415723)

  • 21. Evaluation of botulinum toxin A therapy in children with adductor spasm by gross motor function measure.
    Mall V; Heinen F; Kirschner J; Linder M; Stein S; Michaelis U; Bernius P; Lane M; Korinthenberg R
    J Child Neurol; 2000 Apr; 15(4):214-7. PubMed ID: 10805185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severity of cerebral palsy and likelihood of adverse events after botulinum toxin A injections.
    Swinney CM; Bau K; Burton KLO; O'Flaherty SJ; Bear NL; Paget SP
    Dev Med Child Neurol; 2018 May; 60(5):498-504. PubMed ID: 29451702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
    Read FA; Boyd RN; Barber LA
    Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option.
    Kirschner J; Berweck S; Mall V; Korinthenberg R; Heinen F
    J Neurol; 2001 Apr; 248 Suppl 1():28-30. PubMed ID: 11357236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intramuscular botulinum toxin prior to comprehensive rehabilitation has no added value for improving motor impairments, gait kinematics and goal attainment in walking children with spastic cerebral palsy.
    Schasfoort F; Pangalila R; Sneekes EM; Catsman C; Becher J; Horemans H; Stam HJ; Dallmeijer AJ; Bussmann JBJ
    J Rehabil Med; 2018 Aug; 50(8):732-742. PubMed ID: 30080235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Efficacy and Side Effects of Oral Baclofen Versus Tizanidine Therapy with Adjuvant Botulinum Toxin Type A in Children With Cerebral Palsy and Spastic Equinus Foot Deformity.
    Dai AI; Aksoy SN; Demiryürek AT
    J Child Neurol; 2016 Feb; 31(2):184-9. PubMed ID: 25999301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy.
    Flett PJ; Stern LM; Waddy H; Connell TM; Seeger JD; Gibson SK
    J Paediatr Child Health; 1999 Feb; 35(1):71-7. PubMed ID: 10234640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a framework to define the functional goals and outcomes of botulinum toxin A spasticity treatment relevant to the child and family living with cerebral palsy using the International Classification of Functioning, Disability and Health for Children and Youth.
    Preston N; Clarke M; Bhakta B
    J Rehabil Med; 2011 Nov; 43(11):1010-5. PubMed ID: 22031347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy.
    Ade-Hall RA; Moore AP
    Cochrane Database Syst Rev; 2000; (2):CD001408. PubMed ID: 10796784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short- and long-term effects of selective dorsal rhizotomy on gross motor function in ambulatory children with spastic diplegia.
    van Schie PE; Schothorst M; Dallmeijer AJ; Vermeulen RJ; van Ouwerkerk WJ; Strijers RL; Becher JG
    J Neurosurg Pediatr; 2011 May; 7(5):557-62. PubMed ID: 21529199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
    Mahadevan M; Gruber M; Bilish D; Edwards K; Davies-Payne D; van der Meer G
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Costs and consequences of botulinum toxin type A use. Management of children with cerebral palsy in Germany.
    Ruiz FJ; Guest JF; Lehmann A; Davie AM; Güttler K; Schlüter O; Dreiss G
    Eur J Health Econ; 2004 Oct; 5(3):227-35. PubMed ID: 15714343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parameters for predicting favorable responses to botulinum toxin in children with cerebral palsy.
    Fattal-Valevski A; Giladi N; Domanievitz D; Zuk L; Masterman R; Harel S; Wientroub S; Hayek S
    J Child Neurol; 2002 Apr; 17(4):272-7. PubMed ID: 12088083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of botulinum toxin A in children with cerebral palsy.
    Ross Raftemo AE; Mahendran A; Hollung SJ; Jahnsen RB; Lydersen S; Vik T; Andersen GL
    Tidsskr Nor Laegeforen; 2019 May; 139(8):. PubMed ID: 31062563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu ; Tiebin Yan ; Jianning Mai
    Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional improvement of young children with cerebral palsy treated with integrated/intensive rehabilitation and botulinum toxin injections.
    Bonikowski M; Chrościnska-Krawczyk M; Pyrzanowska W
    Neurol Neurochir Pol; 2023; 57(2):183-188. PubMed ID: 36537370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Best clinical practice in botulinum toxin treatment for children with cerebral palsy.
    Strobl W; Theologis T; Brunner R; Kocer S; Viehweger E; Pascual-Pascual I; Placzek R
    Toxins (Basel); 2015 May; 7(5):1629-48. PubMed ID: 25969944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of group versus individual physiotherapy following lower limb intra-muscular Botulinum Toxin-Type A injections for ambulant children with cerebral palsy: A single-blind randomized comparison trial.
    Thomas RE; Johnston LM; Sakzewski L; Kentish MJ; Boyd RN
    Res Dev Disabil; 2016; 53-54():267-78. PubMed ID: 26955912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GMFCS level improvement in children with cerebral palsy treated with repeat botulinum toxin injections and intensive rehabilitation: A retrospective study.
    Dursun N; Akyuz M; Gokbel T; Akarsu M; Yilmaz E; Karacan C; Dursun E
    J Pediatr Rehabil Med; 2022; 15(1):107-112. PubMed ID: 35275571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
    Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
    Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.